Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s footer has been updated to indicate the ClinicalTrials.gov site revision was bumped from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:16:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added the Bologna location entries 'Province Of Bologna' and 'Bologna, Province Of Bologna, Italy, 15-40138' and removed the lowercase versions. Updated the revision tag to v3.5.2, replacing v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:44.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma tag added and a new resource entry for the Genetic and Rare Diseases Information Center. Page revision updated to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T05:29:30.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:26:14.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Added: Revision: v3.4.2. Removed: the funding-status notice and Revision: v3.4.1 banner. These changes do not affect the study details or the information presented on the page.
    Difference
    0.4%
    Check dated 2026-02-11T10:58:11.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    New site-wide notice about government funding and NIH operating status is displayed at the top of the page. The page header now shows a Revision: v3.4.1, replacing the previous Revision: v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:12.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.